Cargando…
Treatment of COVID-19 with MSCs: how does it work?
Autor principal: | Keating, Armand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science China Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577633/ https://www.ncbi.nlm.nih.gov/pubmed/34755253 http://dx.doi.org/10.1007/s11427-021-2022-5 |
Ejemplares similares
-
T cells at work: How post‐transcriptional mechanisms control T cell homeostasis and activation
por: Jurgens, Anouk P., et al.
Publicado: (2021) -
Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site
por: Schwartz, Zander, et al.
Publicado: (2022) -
How COVID-19 disrupts glycometabolic control
por: Starling, Shimona
Publicado: (2021) -
Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase
por: Xu, Yechun, et al.
Publicado: (2020) -
Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity
por: Schijns, Virgil, et al.
Publicado: (2020)